LGT Group Foundation »

Nektar Therapeutics shares owned by LGT Group Foundation

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by LGT Group Foundation from 13F filings

Historical chart of LGT Group Foundation investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by LGT Group Foundation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by LGT Group Foundation

Quarter filed Position value Share count Share price at filing
2024-06-30 $14k 11k 1.24

More positions owned by LGT Group Foundation

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Mastercard Incorporated Cl A (MA)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Nextera Energy (NEE)
JPMorgan Chase & Co. (JPM)
Ubs Group SHS (UBS)
Tetra Tech (TTEK)
Bank of America Corporation (BAC)

View all positions for LGT Group Foundation

Top funds holding Nektar Therapeutics

Deep Track Capital
BlackRock
BlackRock
Vanguard Group
Eventide Asset Management
Samlyn Capital
Citadel Advisors
PRIMECAP Management Company
Acadian Asset Management
Nantahala Capital Management
TCG Crossover Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Jacobs Levy Equity Management

View all funds holding Nektar Therapeutics